hero section gradient
15 handpicked stocks

The Alzheimer's Treatment Ecosystem

Following the EU regulator's approval of Eli Lilly's Alzheimer's drug, Kisunla, a new investment opportunity has emerged. This theme focuses on companies that provide essential support services, such as genetic testing and advanced imaging, which are crucial for the drug's administration and monitoring.

Author avatar

Han Tan | Market Analyst

Published on July 27

Your Basket's Financial Footprint

Concise interpretation of basket market capitalisation and investor takeaways.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and returns that more closely track broader-market movements.
  • Use as a core, long-term holding rather than a speculative, high-growth allocation.
  • Expect steady, long-term value rather than rapid, short-term gains; growth may be moderate.
Total Market Cap
  • LLY: $756.76B

  • BIIB: $21.44B

  • ILMN: $15.21B

  • Other

About This Group of Stocks

1

Our Expert Thinking

The EU approval of Eli Lilly's Alzheimer's drug Kisunla creates a new investment ecosystem. This breakthrough validates treatments that slow cognitive decline and opens opportunities in the essential support services required for safe drug administration and patient monitoring.

2

What You Need to Know

This group focuses on companies providing critical services like genetic testing to identify suitable patients and advanced medical imaging to monitor for side effects. These services are mandatory requirements, not optional add-ons, creating sustained demand potential.

3

Why These Stocks

These companies were handpicked by professional analysts as the key players in the Alzheimer's treatment support network. They represent the specialized firms positioned to benefit from increased demand as this new class of therapies enters the market.

Why You'll Want to Watch These Stocks

🧬

Breakthrough Moment

The EU approval of Kisunla marks a pivotal shift in Alzheimer's treatment, creating new demand for genetic testing and imaging services that these companies provide.

📈

Mandatory Services

These aren't optional services but required components for safe drug administration. Every patient needs genetic testing and ongoing monitoring, creating sustained revenue streams.

🎯

First-Mover Advantage

As the first approved drug in this new class, Kisunla sets the standard for future treatments, positioning these support companies at the forefront of an emerging market.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Payroll Stocks: Could Gig Worker Rulings Drive New Demand?

Payroll Stocks: Could Gig Worker Rulings Drive New Demand?

A recent New Zealand Supreme Court ruling reclassified Uber drivers as employees, setting a major precedent for the global gig economy. This shift creates a potential investment opportunity in companies that provide essential payroll, benefits, and HR management services, which will be in higher demand as gig workers gain employment status.

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Frequently Asked Questions